Fig. 2
From: Role of 18F-FDG PET/CT in evaluation of recently diagnosed breast cancer patients
A female patient aged 84 arrived with newly diagnosed left breast cancer (IDC grade III). a Whole-body PET MIP image revealed active left breast and left axillary lesions with other innumerable skeletal active lesions. b Axial fused PET/CT picture revealed an ill-defined irregular metabolically active left breast retroareolar soft tissue mass lesion with maximal axial dimensions of 43 × 25 mm and SUVmax of up to 7.33, coupled with modest overlaying skin thickening and surrounding architectural distortion. c Axial fused PET/CT image revealed enlarged metabolically active left axillary lymph node, measuring 11 × 7.5 mm and achieving up to 5.19 SUVmax. d Sagittal fused PET/CT image revealed innumerable hypermetabolic osseous lesions at the spine, achieving up to 10.41 SUVmax